Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-11,900
Closed -$1K 5310
2022
Q3
$1K Buy
11,900
+4,600
+63% +$15.9K ﹤0.01% 4730
2022
Q2
$1K Sell
7,300
-31,200
-81% -$117K ﹤0.01% 4766
2022
Q1
$7K Buy
38,500
+27,600
+253% +$140K ﹤0.01% 3925
2021
Q4
$6K Sell
10,900
-1,000
-8% -$6.83K ﹤0.01% 4112
2021
Q3
$19K Sell
11,900
-23,500
-66% -$193K ﹤0.01% 3399
2021
Q2
$29K Sell
35,400
-1,600
-4% -$11.2K ﹤0.01% 2986
2021
Q1
$24K Sell
37,000
-47,300
-56% -$364K ﹤0.01% 3073
2020
Q4
$61K Sell
84,300
-10,400
-11% -$66.1K ﹤0.01% 1856
2020
Q3
$45K Buy
+94,700
New +$843K ﹤0.01% 1866

Other funds holding VXRT

Cutler Group's VXRT Position: Q1 2023 in Review

Cutler Group sold out of Vaxart (VXRT) in Q1 2023, closing a stake of 500 shares.

Cutler Group first reported a position in VXRT in Q4 2015 and held it in 16 quarters. The position peaked at $148K in Q3 2020. 109 funds tracked by Wall St. Rank hold VXRT as of Q1 2023.

  • Cutler Group reported no remaining Vaxart position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 500 Vaxart shares in Q1 2023.
  • Cutler Group first reported a position in Vaxart in Q4 2015 and held it in 16 quarters.
  • Cutler Group's Vaxart position peaked at $148K in Q3 2020.
  • 109 funds tracked by Wall St. Rank held Vaxart as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.